Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II — sensitization in human adrenocortical cells-Reference-Cited by-同舟云学术

Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II — sensitization in human adrenocortical cells

Published:2007-04-24 Issue:10 Volume:31 Page:1605-1616
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Krug A W,Vleugels K,Schinner S,Lamounier-Zepter V,Ziegler C G,Bornstein S R,Ehrhart-Bornstein M

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://www.nature.com/articles/0803642.pdf

Reference47 articles.

1. Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.

2. Lamounier-Zepter V, Bornstein SR, Ehrhart-Bornstein M . Mechanisms of obesity-related hypertension. Horm Metab Res 2004; 36: 376–380.

3. Hall JE . The kidney, hypertension, and obesity. Hypertension 2003; 41: 625–633.

4. Schram MT, Stehouwer CD . Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 2005; 37S1: 49–55.

5. Goodfriend TL, Egan BM, Kelley DE . Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 401–405.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visceral fat: a bad companion for mineralocorticoid receptor overactivation;Hypertension Research;2023-03-01

2. Nonsteroidal mineralcorticoid receptor antagonists: Novel therapeutic implication in the management of patients with type 2 diabetes;Current Opinion in Pharmacology;2021-10

3. Paradoxical Increase of 24-Hour Urinary Aldosterone Levels in Obese Patients With Resistant Hypertension on a High Salt Diet;American Journal of Hypertension;2020-12-08

4. Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism;Clinical Endocrinology;2020-09-24

5. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension;Hypertension Research;2020-05-18